MedTrace Logo

Dual-focus Soft Contact Lenses for Controlling Rapid Progressive Myopia in Young Adults

NCT06528860 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2024-07-30

No results posted yet for this study

Summary

This study aims to evaluate the effectiveness and acceptability of dual-focus soft contact lenses in controlling rapid myopia progression in adults through a randomized controlled trial. By applying myopia control measures to the adult population, we hope to provide scientific evidence for the effective control of adult myopia progression and offer insights into the understanding of myopia progression during early adulthood.

Conditions

  • Myopia

Interventions

DEVICE

MiSight® 1 day soft contact lenses

Dual-focus contact lenses, daily disposable, material: omafilcon A, water content: 60%.

DEVICE

Proclear® 1 day soft contact lenses

Single-vision contact lenses, daily disposable, material: omafilcon A, water content: 60%.

Sponsors & Collaborators

  • Shanghai Eye Disease Prevention and Treatment Center

    lead OTHER

Principal Investigators

  • Xiangui He · Shanghai Eye Disease Prevention & Treatment Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-31
Primary Completion
2027-06-30
Completion
2027-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06528860 on ClinicalTrials.gov